← Open Payments lookup

MEGAN FLINT: Open Payments

NPI 1710461389 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$977 in 37 payments from 12 companies in 2025. Trend: 2023 $247 · 2024 $607 · 2025 $977

Food & beverage: $977
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP4$192
E.R. Squibb & Sons, L.L.C.1$128
PFIZER INC.8$122
Merck Sharp & Dohme LLC5$100
Boehringer Ingelheim Pharmaceuticals, Inc.4$98
Inspire Medical Systems, Inc.1$84
Alnylam Pharmaceuticals Inc.4$65
Philips North America LLC3$54
BridgeBio Pharma, Inc.3$48
Bayer Healthcare Pharmaceuticals Inc.2$39

Products named: CAMZYOS, LOKELMA, ELIQUIS, JARDIANCE, INSPIRE, VERQUVO, FARXIGA, AMVUTTRA.

Industry payments across MS — which companies pay providers there.